Skip to main content
SupplierTrail

Ancient Formulas, Inc.

FEI 1000219034 · 1235 S Santa Fe St, Wichita, Kansas, 67211, United States

1 warning letter on record

Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports

Get a dated evidence report for this supplierFree · for your supplier file · sample

Import alerts
0
Import refusals (5 years)
0
Warning letters
1
Last FDA action
2026-08-28
2 months ago

FDA record

  1. 2026-08-28
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  2. 2026-08-28
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Foodborne Biological Hazards
    FDA source
  3. 2024-01-25
    RecallRecall F-0930-2024 · Class 3 · Product is sub-potent for Vitamin D and label contains incorrect percent daily value.
    Healthprint Vitamin D3 5000 Dietary Supplement, 200 tablets, packaged in plastic bottle.
    Source: FDA Enforcement Reports
  4. 2023-10-27
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  5. 2023-10-27
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Foodborne Biological Hazards
    FDA source
  6. 2021-10-21
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Foodborne Biological Hazards
    FDA source
  7. 2021-10-21
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  8. 2017-06-16
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Foodborne Biological Hazards
    FDA source
  9. 2017-06-16
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  10. 2014-02-11
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Foodborne Biological Hazards
    FDA source
  11. 2014-02-11
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  12. 2013-03-22
    RecallRecall F-1802-2013 · Class 2 · Product contains higher levels of niacin than claimed on label .
    Bulk tablet label: Keytabs W.O. Glandulars (pink)
    Source: FDA Enforcement Reports
  13. 2013-03-22
    RecallRecall F-1803-2013 · Class 2 · Product contains higher levels of niacin than claimed on label .
    KEYTABS (Without Iron, Copper or Glandulars), packaged in 180-tablet bottles, a product of The Key Company, St. Louis, MO.
    Source: FDA Enforcement Reports
  14. 2011-08-05
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  15. 2011-06-24
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Pesticides and Chemical Contaminants
    FDA source
  16. 2011-06-24
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source
  17. 2011-06-24
    InspectionFDA inspection · Classification: No Action Indicated (NAI)
    Project area: Foodborne Biological Hazards
    FDA source
  18. 2011-02-09
    Warning letterFDA Warning Letter (CFSAN)
    FDA source
  19. 2010-10-21
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Pesticides and Chemical Contaminants
    FDA source
  20. 2010-10-21
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Foodborne Biological Hazards
    FDA source
  21. 2010-10-21
    InspectionFDA inspection · Classification: Voluntary Action Indicated (VAI)
    Project area: Food Composition, Standards, Labeling and Econ
    FDA source